BioCatalystWatch
INDPWorkspace / INDP / OverviewCompany library

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. (INDP)

Website

Price
Market cap
Next catalyst—
Cash
Latest company release · Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update ↗

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

TLR1 × TLR2 × TLR4 × TLR6 × TLR8 × TLR9 × NOD2 × STING

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

Latest company release · Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update ↗

INDP PR & News

INDP SEC archive